Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Agents in development for prostate cancer prevention.

William G Nelson¹

¹Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, UK. bnelson@jhmi.edu

Expert Opinion on Investigational Drugs

|November 30, 2004

Summary

Prostate cancer mortality is preventable through targeting androgen signaling and inflammation. New drugs, including 5alpha-reductase inhibitors and antioxidants, show promise for prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Structural and cellular insights into DCTPP1 antagonists and their synergistic action with DNMT inhibitors.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

RRM1 inhibition sensitizes lung adenocarcinoma to decitabine treatment.

Cell death & disease·2026

Same author

A transition zone enriched <i>WIF1</i> ⁺ basal cell subtype is associated with benign prostatic hyperplasia.

bioRxiv : the preprint server for biology·2025

Same author

Cancer researchers as storytellers for the lay public.

Trends in cancer·2024

Same author

Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer.

Nature communications·2024

Same author

Disparities in Cancer Stage Outcomes by Catchment Areas for a Comprehensive Cancer Center.

JAMA network open·2024

Area of Science:

Oncology
Preventive Medicine
Molecular Biology

Background:

Prostate cancer mortality is a significant public health concern, yet evidence suggests it is preventable.
Androgen signaling is crucial for prostate development and a validated target for advanced prostate cancer treatment.
Emerging research implicates chronic inflammation in prostate cancer development, suggesting new avenues for prevention.

Purpose of the Study:

To review the rational development of novel agents and strategies for prostate cancer prevention.
To explore the role of androgen deprivation and inflammation in prostate cancer etiology and prevention.
To discuss current research progress in understanding prostate cancer pathogenesis for preventive applications.

Main Methods:

Review of epidemiological evidence and molecular pathogenesis of prostate cancer.
Analysis of clinical trial data for 5alpha-reductase inhibitors in prostate cancer prevention.
Evaluation of antioxidants and anti-inflammatory drugs for their potential in preventing carcinogen-induced genome damage.

Main Results:

5alpha-reductase inhibitors are in pivotal clinical trials for prostate cancer prevention.
Antioxidants and anti-inflammatory agents are being developed to mitigate oxidative stress and inflammation linked to cancer.
Understanding prostate cancer etiology informs the development of targeted preventive therapies.

Conclusions:

Targeting androgen signaling pathways offers a viable strategy for prostate cancer prevention.
Modulating prostate inflammation and oxidative stress presents promising preventive approaches.
Continued research into prostate cancer's molecular underpinnings is essential for advancing prevention.

Related Experiment Videos